Benjamin Marchandot

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Should Cardiologists be Concerned About Large Language Model-Based Chatbots From a Patient-Complaint Perspective?

Should Cardiologists be Concerned About Large Language Model-Based Chatbots From a Patient-Complaint Perspective?

Journal: Journal of the American Heart Association

Published: August 31, 2026

Endometriosis as a cardiovascular risk enhancer.

Endometriosis as a cardiovascular risk enhancer.

Journal: European heart journal

Published: August 05, 2026

Current Practices and Expectations on the Environmental Impact of Interventional Cardiology: The GREEN-CCF Study.

Current Practices and Expectations on the Environmental Impact of Interventional Cardiology: The GREEN-CCF Study.

Journal: Journal of the American Heart Association

Published: July 17, 2026

SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.

SGLT2 Inhibition as a Novel Therapeutic Strategy in Rheumatic Heart Disease.

Journal: JACC. Asia

Published: February 08, 2026

Rheumatic Heart Disease: Inflammation, Immune Pathways, Valve Remodeling, and the Promise of SGLT2 Inhibitors.

Rheumatic Heart Disease: Inflammation, Immune Pathways, Valve Remodeling, and the Promise of SGLT2 Inhibitors.

Journal: JACC. Basic to translational science

Published: February 05, 2026

Post-TAVR Bleeding in Atrial Fibrillation Patients Treated With Apixaban or Rivaroxaban.

Post-TAVR Bleeding in Atrial Fibrillation Patients Treated With Apixaban or Rivaroxaban.

Journal: The American journal of cardiology

Published: January 26, 2026

Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.

Detrimental Effect of Plasma From Patients With Severe Aortic Stenosis on Valvular Endothelial Cells: Role of Proinflammatory Cytokines and Factor Xa.

Journal: Journal of the American Heart Association

Published: November 26, 2025

Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study.

Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study.

Journal: Journal of clinical medicine

Published: November 08, 2025

SGLT2 Inhibitors and Mortality in Endometriosis With Type 2 Diabetes: A Propensity-Matched Analysis.

SGLT2 Inhibitors and Mortality in Endometriosis With Type 2 Diabetes: A Propensity-Matched Analysis.

Journal: JACC. Advances

Published: November 07, 2025

Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study.

Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study.

Journal: Journal of clinical medicine

Published: September 01, 2025

SGLT2 Inhibition After Aortic Valve Replacement: The Role of the Native Valve.

SGLT2 Inhibition After Aortic Valve Replacement: The Role of the Native Valve.

Journal: JACC. Advances

Published: July 02, 2025

Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration.

Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration.

Journal: Journal of the American Heart Association

Published: June 18, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026